Skip to main content
TipRanks
Go Ultimate75% OFF

JOSEPH C MCNAY Insider Profile

4 Followers

JOSEPH C MCNAY, Director at RegeneRx Biopharmaceuticals, holds 6.52M shares in RegeneRx Biopharmaceuticals (Ticker: RGRX). Most recently, JOSEPH C MCNAY Bought 522,280 shares of RegeneRx Biopharmaceuticals on Jan 08, 2019 for an estimated value of $31.34K.

JOSEPH C MCNAY's Trading History

RGRX
RegeneRx Biopharmaceuticals
Jan 08, 2019DirectorInformative Buy31.34K$1.13M
RGRX
Insider Shares: 6.52M (4.54%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 08, 2019Informative Buy$31.34K522,280$0.06+44.10%
Sep 13, 2018Informative Buy$125.35K2,089,120$0.06-21.00%
Jul 09, 2018Informative Buy$62.67K1,044,560$0.06-21.10%
Apr 02, 2018Informative Buy$62.67K1,044,560$0.06+11.50%
Oct 20, 2017Informative Buy$72.67K484,491$0.15-45.40%

You May Also Like

JOSEPH C MCNAY insider profile FAQ

What is the percentage of profitable transactions made by JOSEPH C MCNAY?
The percentage of profitable transactions made by JOSEPH C MCNAY is 40%.
What is the average return per transaction made by JOSEPH C MCNAY?
The average return per transaction made by JOSEPH C MCNAY is -6.30%.
What stocks does JOSEPH C MCNAY hold?
JOSEPH C MCNAY holds: RGRX stocks.
What was JOSEPH C MCNAY’s latest transaction?
JOSEPH C MCNAY’s latest transaction was an Informative Buy of $31.34K.
What was JOSEPH C MCNAY's most profitable transaction?
JOSEPH C MCNAY’s most profitable transaction was an Informative Buy of RGRX stock on January 8, 2019. The return on the trade was 44.10%.
What is JOSEPH C MCNAY's role in RegeneRx Biopharmaceuticals?
JOSEPH C MCNAY's role in RegeneRx Biopharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.